Umavida Pharma Private Limited — Zinc Exporter Profile

Geopolitical & Trade Policy Impact on Umavida Pharma Private Limited's Zinc Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Umavida Pharma. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has highlighted that such disruptions could result in losses ranging from ₹2,500 crore to ₹5,000 crore for the industry. (outlookbusiness.com)

Conversely, trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies to capture a larger share of the American market. However, the imposition of tariffs by the U.S. on pharmaceutical imports poses a significant challenge. In August 2025, the U.S. administration imposed broad tariffs on imports from over 60 countries, including India, with rates reaching as high as 39%. This move has raised concerns among Indian exporters about increased costs and potential loss of market share. (apnews.com)

In the European Union, regulatory changes such as the Falsified Medicines Directive necessitate stringent compliance measures. For companies like Umavida Pharma, this means investing in advanced serialization and traceability systems to ensure continued access to the lucrative EU market.